Clinical Trials Directory

Trials / Sponsors / Shijiazhuang Yiling Pharmaceutical Co. Ltd

Shijiazhuang Yiling Pharmaceutical Co. Ltd

Industry · 13 registered clinical trials — 4 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study to Evaluate the Effect of XY0206 on the QTc Interval in Chinese Healthy Participants
Acute Myeloid Leukemia With FLT3/ITD Mutation
Phase 12025-07-06
Enrolling By InvitationA Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke
Stroke, Ischemic
Phase 2 / Phase 32024-12-15
CompletedA Study on the Substance Balance of [14C]XY0206 in Healthy Adult Chinese Men
Metabolism of Radioactive Substances
Phase 12024-11-06
RecruitingA Study of Bio-008 in Subjects With Advanced or Metastatic Solid Tumours
Solid Tumor, Adult
Phase 12023-07-17
Not Yet RecruitingA Study of XY0206 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory AML With FLT3-ITD-Mutati
Acute Myeloid Leukemia With FLT3/ITD Mutation
Phase 32023-06-15
UnknownA Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke
Acute Ischemic Stroke
Phase 22022-09-24
CompletedA Phase # Clinical Study Trial of Felbinac Trometamol Injection in China
Pain
Phase 32021-07-23
CompletedA Phase Ⅲ Clinical Study Trial of Felbinac Trometamol Injection in China
Pain
Phase 32021-04-25
CompletedStudy on the Safety, Tolerance and Pharmacokinetics of Phenlarmide Tablets
Parkinson Disease
Phase 12021-02-23
UnknownA Study of XY0206 Tablets in Patients With Relapsed / Refractory Acute Myeloid Leukemia
Acute Myeloid Leukemia
Phase 12020-09-15
CompletedA Phase Ⅱ Clinical Study Trial of Felbinac Trometamol Injection in China
Pain
Phase 22019-03-27
UnknownA Study of XY0206 in Subjects With Advanced or Metastatic Solid Tumours
Advanced or Metastatic Solid Tumours
Phase 12018-12-19
CompletedA Phase I Clinical Study Trial of Felbinac Trometamol Injection in China
Pain
Phase 12018-07-10